Search Results Page
Search Results
1 - 3 of 3 (0.22 seconds)Commissioner Of Income-Tax vs Glaxo Laboratories (India) Ltd. on 28 September, 1989
tax Act by relying on CIT v. Glaxo Laboratories India Ltd., (supra), the
facts in this case are distinguishable to the present case.
The Dy. Cit, Circle-1(1)(2),, ... vs Cadila Healthcare Ltd.,, Ahmedabad on 3 March, 2017
21. With regard to expenditure incurred to carryout trade mark
registration in US and UK. These are not capital expenditure, as held in
the case of Cadila Healthcare Ltd. v. ACIT (supra), the expenditure
incurred for protection of its running business without generating any new
asset, is an allowable expenditure. Therefore, we are inclined to delete
the addition made by the Assessing Officer.
1